$31.60
At close: Jun 30 EDT
$33.43
1.835.78%
Pre-Market: 5:47 PM EDT
Comments
Loading...
Harmony Biosciences Hldgs Insider Trading Activity | NASDAQ:HRMY | Benzinga
Track the latest Harmony Biosciences Hldgs insider trading activity. Stay informed on recent buys, sells, and market impact for Harmony Biosciences Hldgs stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Harmony Biosciences Holdings Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On April 3, 2025, Sandip Kapadia, the company's CHIEF FINANCIAL OFFICER sold 6.99K shares for $32.54 each.
Ownership Statistics for Harmony Biosciences Holdings Inc
Shares Outstanding
57.424M
Insider Shares Owned
269.371K
Insider Percentage Owned
0.47%
Institutional Shares Held
30.679M
Institutional Percentage Held
53.4%
| Apr 03, 2025 | Sandip Kapadia | CHIEF FINANCIAL OFFICER | -6.99K | $32.54 | -$227.39K | SELL | -100.00% | 0.00 | Apr 01 | View |
| Mar 05, 2025 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $20.45 | -$119.07K | SELL-OPTIONS | 0.00% | 0.00 | Mar 03 | View |
| Jan 28, 2025 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $34.06 | -$188.98K | SELL-OPTIONS | 0.00% | 0.00 | Jan 24 - Jan 27 | View |
| Jan 28, 2025 | Sandip Kapadia | CHIEF FINANCIAL OFFICER | 0.00 | $38.03 | -$144.97K | SELL-OPTIONS | 0.00% | 0.00 | Jan 24 - Jan 27 | View |
| Jan 23, 2025 | Jeffrey Dayno | PRESIDENT, CEO | 0.00 | $24.18 | -$615.66K | SELL-OPTIONS | 0.00% | 0.00 | Jan 21 | View |
| Jan 23, 2025 | Sandip Kapadia | CHIEF FINANCIAL OFFICER | 0.00 | $34.61 | -$278.85K | SELL-OPTIONS | 0.00% | 0.00 | Jan 21 | View |
| Jan 21, 2025 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $35.47 | -$124.52K | SELL-OPTIONS | 0.00% | 0.00 | Jan 16 - Jan 21 | View |
| Jan 16, 2025 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $35.22 | -$37.49K | SELL-OPTIONS | 0.00% | 0.00 | Jan 15 | View |
| Jan 15, 2025 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $35.24 | -$25.85K | SELL-OPTIONS | 0.00% | 0.00 | Jan 13 | View |
| Nov 05, 2024 | Valor IV Pharma Holdings LLCValor Management LPValor Equity Capital IV LLCValor Equity Associates IV LPVALOR EQUITY PARTNERS IV LPVALOR EQUITY PARTNERS IVA LPVALOR EQUITY PARTNERS IVB LPAntonio GraciasJuan Sabater | DIRECTOR | -4.60M | $30.30 | -$139.39M | SELL | -41.01% | 6.62M | Nov 01 - Nov 05 | View |
| Nov 05, 2024 | Marshman Fund Trust II | 10% OWNER | -4.60M | $30.30 | -$139.39M | SELL | -43.19% | 6.05M | Nov 01 - Nov 05 | View |
| Oct 31, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $32.24 | -$354.11K | SELL-OPTIONS | 0.00% | 0.00 | Oct 29 | View |
| Oct 07, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | -36.36K | $35.06 | -$1.27M | SELL | -100.00% | 0.00 | Oct 03 | View |
| Oct 02, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $32.10 | -$6.48K | SELL-OPTIONS | 0.00% | 0.00 | Oct 01 | View |
| Oct 01, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $32.02 | -$574.65K | SELL-OPTIONS | 0.00% | 0.00 | Sep 30 | View |
| Sep 30, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $32.02 | -$3.21K | SELL-OPTIONS | 0.00% | 0.00 | Sep 27 | View |
| Mar 18, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $20.11 | -$284.86K | SELL-OPTIONS | 0.00% | 0.00 | Mar 15 | View |
| Mar 11, 2024 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $20.11 | -$4.61K | SELL-OPTIONS | 0.00% | 0.00 | Mar 08 | View |
| Dec 16, 2022 | Jack Nielsen | — | -2.83K | $59.96 | -$169.93K | SELL | -0.11% | 2.57M | Dec 14 | View |
| Dec 14, 2022 | Andreas Wicki | DIRECTOR | -28.84K | $60.31 | -$1.74M | SELL | -1.32% | 2.15M | Dec 12 - Dec 14 | View |
| Dec 09, 2022 | Jack Nielsen | — | -110.75K | $60.16 | -$6.66M | SELL | -4.13% | 2.57M | Dec 07 - Dec 09 | View |
| Dec 07, 2022 | Andreas Wicki | DIRECTOR | -77.85K | $61.23 | -$4.77M | SELL | -3.45% | 2.18M | Dec 05 | View |
| Dec 05, 2022 | Andrew Serafin | CHIEF STRATEGY OFFICER | 0.00 | $34.18 | -$1.97M | SELL-OPTIONS | 0.00% | 0.00 | Dec 02 | View |
| Dec 01, 2022 | Jack Nielsen | — | -129.65K | $59.29 | -$7.69M | SELL | -4.61% | 2.68M | Nov 29 - Dec 01 | View |
| Nov 22, 2022 | Jack Nielsen | DIRECTOR | -77.60K | $57.27 | -$4.44M | SELL | -2.68% | 2.81M | Nov 18 - Nov 22 | View |
| Nov 16, 2022 | Andreas Wicki | DIRECTOR | -51.28K | $59.31 | -$3.04M | SELL | -2.22% | 2.25M | Nov 14 - Nov 15 | View |
| Nov 15, 2022 | Jack Nielsen | DIRECTOR | -158.40K | $57.58 | -$9.12M | SELL | -5.19% | 2.89M | Nov 11 - Nov 15 | View |
| Nov 10, 2022 | Andreas Wicki | DIRECTOR | -129.41K | $58.89 | -$7.62M | SELL | -5.31% | 2.31M | Nov 08 - Nov 10 | View |
| Nov 04, 2022 | Andreas Wicki | DIRECTOR | -576.77K | $59.09 | -$34.08M | SELL | -19.15% | 2.44M | Nov 02 - Nov 04 | View |
| Nov 04, 2022 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $34.12 | -$777.03K | SELL-OPTIONS | 0.00% | 0.00 | Nov 03 | View |
| Nov 02, 2022 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $31.66 | -$703.26K | SELL-OPTIONS | 0.00% | 0.00 | Nov 01 | View |
| Oct 04, 2022 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $26.45 | -$443.85K | SELL-OPTIONS | 0.00% | 0.00 | Oct 03 | View |
| Aug 23, 2022 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $35.50 | -$666.42K | SELL-OPTIONS | 0.00% | 0.00 | Aug 22 | View |
| Aug 16, 2022 | John Jacobs | PRESIDENT, CEO | 0.00 | $29.65 | -$1.71M | SELL-OPTIONS | 0.00% | 0.00 | Aug 15 | View |
| Aug 10, 2022 | Andreas Wicki | DIRECTOR | -578.55K | $53.77 | -$31.11M | SELL | -16.11% | 3.01M | Aug 08 - Aug 10 | View |
| Aug 08, 2022 | Jack Nielsen | DIRECTOR | -250.00K | $52.73 | -$13.18M | SELL | -7.58% | 3.05M | Aug 04 - Aug 08 | View |
| Aug 05, 2022 | Andreas Wicki | DIRECTOR | -72.59K | $52.73 | -$3.83M | SELL | -1.98% | 3.59M | Aug 03 - Aug 05 | View |
| Aug 03, 2022 | Jack Nielsen | DIRECTOR | -75.12K | $55.22 | -$4.15M | SELL | -2.23% | 3.30M | Aug 02 | View |
| Jul 20, 2022 | Jack Nielsen | DIRECTOR | -40.09K | $55.19 | -$2.21M | SELL | -1.17% | 3.38M | Jul 18 | View |
| Jul 15, 2022 | Jack Nielsen | DIRECTOR | -5.77K | $55.04 | -$317.75K | SELL | -0.17% | 3.42M | Jul 13 | View |
| Jul 12, 2022 | Jack Nielsen | DIRECTOR | -10.77K | $55.05 | -$592.81K | SELL | -0.31% | 3.42M | Jul 08 - Jul 11 | View |
| Jul 07, 2022 | Jack Nielsen | DIRECTOR | -300.74K | $55.39 | -$16.66M | SELL | -8.06% | 3.43M | Jul 05 - Jul 07 | View |
| Jul 01, 2022 | Jack Nielsen | DIRECTOR | -14.57K | $52.08 | -$758.84K | SELL | -0.39% | 3.73M | Jun 29 - Jul 01 | View |
| Jun 28, 2022 | Jack Nielsen | DIRECTOR | -100.46K | $52.33 | -$5.26M | SELL | -2.61% | 3.75M | Jun 24 - Jun 28 | View |
| Jun 16, 2022 | John Jacobs | PRESIDENT, CEO | 0.00 | $26.82 | -$557.98K | SELL-OPTIONS | 0.00% | 0.00 | Jun 15 | View |
| Jun 14, 2022 | John Jacobs | PRESIDENT, CEO | 0.00 | $26.20 | -$898.91K | SELL-OPTIONS | 0.00% | 0.00 | Jun 13 | View |
| Apr 25, 2022 | Jack Nielsen | DIRECTOR | -6.55K | $52.19 | -$342.05K | SELL | -0.17% | 3.85M | Apr 21 | View |
| Apr 20, 2022 | Jack Nielsen | DIRECTOR | -132.26K | $52.30 | -$6.92M | SELL | -3.32% | 3.85M | Apr 18 - Apr 20 | View |
| Apr 14, 2022 | Jack Nielsen | DIRECTOR | -119.83K | $51.07 | -$6.12M | SELL | -2.92% | 3.99M | Apr 12 - Apr 14 | View |
| Apr 11, 2022 | Jack Nielsen | DIRECTOR | -11.16K | $50.17 | -$560.10K | SELL | -0.27% | 4.09M | Apr 07 - Apr 08 | View |
| Apr 06, 2022 | Jack Nielsen | DIRECTOR | -21.39K | $50.24 | -$1.07M | SELL | -0.52% | 4.10M | Apr 04 - Apr 05 | View |
| Apr 05, 2022 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $36.81 | -$370.87K | SELL-OPTIONS | 0.00% | 0.00 | Apr 01 | View |
| Apr 01, 2022 | Jack Nielsen | DIRECTOR | -37.39K | $50.21 | -$1.88M | SELL | -0.90% | 4.12M | Mar 30 - Apr 01 | View |
| Mar 29, 2022 | Jack Nielsen | DIRECTOR | -114.12K | $50.66 | -$5.78M | SELL | -2.67% | 4.15M | Mar 25 - Mar 29 | View |
| Mar 24, 2022 | Jack Nielsen | DIRECTOR | -36.29K | $50.16 | -$1.82M | SELL | -0.85% | 4.25M | Mar 22 - Mar 24 | View |
| Mar 21, 2022 | Jack Nielsen | DIRECTOR | -16.18K | $50.08 | -$810.37K | SELL | -0.38% | 4.29M | Mar 17 - Mar 18 | View |
| Mar 18, 2022 | John Jacobs | PRESIDENT, CEO | 0.00 | $26.77 | -$556.52K | SELL-OPTIONS | 0.00% | 0.00 | Mar 16 | View |
| Mar 16, 2022 | John Jacobs | PRESIDENT, CEO | 0.00 | $25.31 | -$854.27K | SELL-OPTIONS | 0.00% | 0.00 | Mar 14 | View |
| Mar 11, 2022 | Andreas Wicki | DIRECTOR | -285.59K | $45.24 | -$12.92M | SELL | -7.23% | 3.66M | Mar 09 - Mar 11 | View |
| Mar 04, 2022 | Andreas Wicki | DIRECTOR | -596.43K | $40.62 | -$24.23M | SELL | -13.12% | 3.95M | Mar 01 - Mar 03 | View |
| Mar 02, 2022 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $29.43 | -$315.60K | SELL-OPTIONS | 0.00% | 0.00 | Feb 28 - Mar 01 | View |
| Feb 18, 2022 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | -4.06K | $32.02 | -$234.00K | SELL | -100.00% | 0.00 | Feb 16 - Feb 17 | View |
| Jan 10, 2022 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $24.29 | -$196.91K | SELL-OPTIONS | 0.00% | 0.00 | Jan 06 | View |
| Jan 05, 2022 | John Jacobs | PRESIDENT, CEO | 0.00 | $26.69 | -$1.06M | SELL-OPTIONS | 0.00% | 0.00 | Jan 03 - Jan 04 | View |
| Dec 29, 2021 | John Jacobs | PRESIDENT, CEO | 0.00 | $26.62 | -$47.85K | SELL-OPTIONS | 0.00% | 0.00 | Dec 27 | View |
| Dec 15, 2021 | John Jacobs | PRESIDENT, CEO | 0.00 | $23.22 | -$749.91K | SELL-OPTIONS | 0.00% | 0.00 | Dec 13 | View |
| Dec 10, 2021 | Andreas Wicki | DIRECTOR | -27.27K | $40.09 | -$1.09M | SELL | -0.60% | 4.55M | Dec 08 - Dec 10 | View |
| Nov 17, 2021 | Andreas Wicki | DIRECTOR | -69.27K | $41.60 | -$2.88M | SELL | -1.49% | 4.57M | Nov 15 - Nov 17 | View |
| Nov 03, 2021 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $24.95 | -$334.54K | SELL-OPTIONS | 0.00% | 0.00 | Nov 01 | View |
| Oct 20, 2021 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $25.75 | -$637.94K | SELL-OPTIONS | 0.00% | 0.00 | Oct 19 | View |
| Oct 07, 2021 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $24.16 | -$57.38K | SELL-OPTIONS | 0.00% | 0.00 | Oct 06 | View |
| Sep 14, 2021 | John Jacobs | PRESIDENT, CEO | 0.00 | $22.08 | -$692.76K | SELL-OPTIONS | 0.00% | 0.00 | Sep 13 | View |
| Sep 09, 2021 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $22.61 | -$143.90K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | View |
| Sep 09, 2021 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $22.90 | -$293.58K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | View |
| Sep 03, 2021 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $20.92 | -$253.93K | SELL-OPTIONS | 0.00% | 0.00 | Sep 01 | View |
| Aug 30, 2021 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $21.67 | -$269.08K | SELL-OPTIONS | 0.00% | 0.00 | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $21.67 | -$134.53K | SELL-OPTIONS | 0.00% | 0.00 | Aug 26 - Aug 27 | View |
| Aug 11, 2021 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $19.22 | -$218.85K | SELL-OPTIONS | 0.00% | 0.00 | Aug 10 | View |
| Jul 23, 2021 | Jeffrey Dayno | CHIEF MEDICAL OFFICER | 0.00 | $19.11 | -$1.09K | SELL-OPTIONS | 0.00% | 0.00 | Jul 22 | View |
| Jun 16, 2021 | Jeffrey Dierks | CHIEF COMMERCIAL OFFICER | 0.00 | $19.77 | -$346.51K | SELL-OPTIONS | 0.00% | 0.00 | Jun 15 | View |
| Oct 16, 2020 | Marshman Fund Trust II | — | 339.48K | $24.00 | $8.15M | PURCHASE | 3.29% | 10.65M | Aug 21 | View |
| Aug 27, 2020 | Jack Nielsen | — | 4.75K | $34.28 | $162.67K | PURCHASE | 12.50% | 42.70K | Aug 25 - Aug 26 | View |
| Aug 25, 2020 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | — | 4.41M | $24.00 | $3.18M | DERIVATIVE CONVERSION | ∞ | 4.41M | Aug 21 | View |
| Aug 24, 2020 | Jack Nielsen | — | 37.96K | $27.58 | $1.05M | PURCHASE | ∞ | 37.96K | Aug 20 - Aug 24 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
